Generate:Biomedicines vs Insilico Medicine
Which Healthcare AI tool is better in 2026?
Generate:Biomedicines
Generative AI for programmable protein therapeutics
Insilico Medicine
Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms.
Side-by-side
Generate:Biomedicines is the more established option (raised $700M); pricing is comparable on both sides.
| Metric | Generate:Biomedicines | Insilico Medicine |
|---|---|---|
| Taglinei | Generative AI for programmable protein therapeutics | Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms. |
| Foundedi | 2018🏆 | — |
| HQi | Somerville, United States | US |
| Employeesi | — | 201-500🏆 |
| Neuron scorei | 77🏆 | 72 |
| Total fundingi | $700M🏆 | $510M |
| Latest roundi | Series C · Sep 2023 | Series E · Mar 2025 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Generate:Biomedicines and Insilico Medicine.
| Capability | Generate:Biomedicines | Insilico Medicine |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Generate:Biomedicines
- Has raised more capital ($700M vs $510M)
- Higher Neuron score (77 vs 72)
- Newer company (2018)
🔵 Strengths of Insilico Medicine
- Strong in AI Healthcare
Which should you choose?
Choose Insilico Medicine if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Generate:Biomedicines if you want the most established option — it has raised $700M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Generate:Biomedicines vs Insilico Medicine — which is better?
It depends on your priority. Generate:Biomedicines has raised more capital and is the more established option; Insilico Medicine has broader feature depth. See the side-by-side table above.
Is Generate:Biomedicines cheaper than Insilico Medicine?
No — Insilico Medicine's cheapest paid plan is Enterprise · Contact sales, while Generate:Biomedicines's is Custom.
Do Generate:Biomedicines and Insilico Medicine offer free plans?
Generate:Biomedicines: Paid only. Insilico Medicine: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.